These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37552278)

  • 1. Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease.
    Angius F; Mocci I; Ercoli T; Loy F; Fadda L; Palmas MF; Cannas G; Manzin A; Defazio G; Carta AR
    J Neurol; 2023 Nov; 270(11):5613-5621. PubMed ID: 37552278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.
    Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q
    medRxiv; 2024 Jun; ():. PubMed ID: 38978648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?
    Mollenhauer B
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S76-9. PubMed ID: 24262194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.
    Oeckl P; Metzger F; Nagl M; von Arnim CA; Halbgebauer S; Steinacker P; Ludolph AC; Otto M
    Mol Cell Proteomics; 2016 Oct; 15(10):3126-3138. PubMed ID: 27507836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls.
    Schmid S; Goldberg-Bockhorn E; Schwarz S; Rotter N; Kassubek J; Del Tredici K; Pinkhardt E; Otto M; Ludolph AC; Oeckl P
    J Neurol; 2018 Jun; 265(6):1334-1337. PubMed ID: 29600388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms.
    Winkel I; Ermann N; Żelwetro A; Sambor B; Mroczko B; Kornhuber J; Paradowski B; Lewczuk P
    J Neural Transm (Vienna); 2021 Jun; 128(6):817-825. PubMed ID: 34036433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
    Goldman JG; Andrews H; Amara A; Naito A; Alcalay RN; Shaw LM; Taylor P; Xie T; Tuite P; Henchcliffe C; Hogarth P; Frank S; Saint-Hilaire MH; Frasier M; Arnedo V; Reimer AN; Sutherland M; Swanson-Fischer C; Gwinn K; ; Kang UJ
    Mov Disord; 2018 Feb; 33(2):282-288. PubMed ID: 29205509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease.
    De Bartolo MI; Vivacqua G; Belvisi D; Mancinelli R; Fabbrini A; Manzo N; Costanzo M; Leodori G; Conte A; Fabbrini G; Morini S; Berardelli A
    Ann Neurol; 2023 Mar; 93(3):446-459. PubMed ID: 36385395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.
    Manne S; Kondru N; Jin H; Serrano GE; Anantharam V; Kanthasamy A; Adler CH; Beach TG; Kanthasamy AG
    Mov Disord; 2020 Dec; 35(12):2230-2239. PubMed ID: 32960470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
    Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
    Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.
    Majbour N; Aasly J; Abdi I; Ghanem S; Erskine D; van de Berg W; El-Agnaf O
    Neurology; 2022 Nov; 99(21):e2417-e2427. PubMed ID: 36096686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.
    Fernández-Espejo E; Rodríguez de Fonseca F; Suárez J; Tolosa E; Vilas D; Aldecoa I; Berenguer J; Damas-Hermoso F
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34062880
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms.
    Petricca L; Chiki N; Hanna-El-Daher L; Aeschbach L; Burai R; Stoops E; Fares MB; Lashuel HA
    J Parkinsons Dis; 2022; 12(5):1449-1462. PubMed ID: 35527570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive Monitoring of α-Synuclein in Saliva for Parkinson's Disease Using Organic Electrolyte-Gated FET Aptasensor.
    Massey RS; McConnell EM; Chan D; Holahan MR; DeRosa MC; Prakash R
    ACS Sens; 2023 Aug; 8(8):3116-3126. PubMed ID: 37506391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.
    Shahnawaz M; Tokuda T; Waragai M; Mendez N; Ishii R; Trenkwalder C; Mollenhauer B; Soto C
    JAMA Neurol; 2017 Feb; 74(2):163-172. PubMed ID: 27918765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic Parkinson's disease?
    Fernández E; García-Moreno JM; Martín de Pablos A; Chacón J
    Antioxid Redox Signal; 2013 Sep; 19(9):912-8. PubMed ID: 23418747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.